Genalumab

· Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Genalumab, covering 2024-09-23 to 2024-09-23. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis. [NA]

See pricing